539 related articles for article (PubMed ID: 17476346)
1. Tregs and rethinking cancer immunotherapy.
Curiel TJ
J Clin Invest; 2007 May; 117(5):1167-74. PubMed ID: 17476346
[TBL] [Abstract][Full Text] [Related]
2. Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines.
Ruter J; Barnett BG; Kryczek I; Brumlik MJ; Daniel BJ; Coukos G; Zou W; Curiel TJ
Front Biosci (Landmark Ed); 2009 Jan; 14(5):1761-70. PubMed ID: 19273160
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells in tumor immunity.
Nishikawa H; Sakaguchi S
Int J Cancer; 2010 Aug; 127(4):759-67. PubMed ID: 20518016
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
[TBL] [Abstract][Full Text] [Related]
6. [Regulatory T cells: A target in anticancer immunotherapy].
Enokida T; Nishikawa H
Nihon Rinsho; 2017 Feb; 75(2):181-187. PubMed ID: 30562850
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells in ovarian cancer: biology and therapeutic potential.
Barnett B; Kryczek I; Cheng P; Zou W; Curiel TJ
Am J Reprod Immunol; 2005 Dec; 54(6):369-77. PubMed ID: 16305662
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
[TBL] [Abstract][Full Text] [Related]
9. Targeting regulatory T cells.
Ménétrier-Caux C; Curiel T; Faget J; Manuel M; Caux C; Zou W
Target Oncol; 2012 Mar; 7(1):15-28. PubMed ID: 22327882
[TBL] [Abstract][Full Text] [Related]
10. Exploiting regulatory T-cell populations for the immunotherapy of cancer.
van der Vliet HJ; Koon HB; Atkins MB; Balk SP; Exley MA
J Immunother; 2007 Sep; 30(6):591-5. PubMed ID: 17667522
[TBL] [Abstract][Full Text] [Related]
11. CD4+ regulatory cells as a potential immunotherapy.
Fehérvari Z; Sakaguchi S
Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1647-61. PubMed ID: 16147529
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells: potential target in anticancer immunotherapy.
Juang CM; Hung CF; Yeh JY; Horng HC; Twu NF; Cheng MH; Wen KC; Yuan CC; Chao KC; Wu TC; Yen MS
Taiwan J Obstet Gynecol; 2007 Sep; 46(3):215-21. PubMed ID: 17962099
[TBL] [Abstract][Full Text] [Related]
13. [Anti-CCR4 mAb and regulatory T cells].
Kurose K; Ohue Y; Oka M
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1150-5. PubMed ID: 24047773
[TBL] [Abstract][Full Text] [Related]
14. Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancers.
Knutson KL
Future Oncol; 2006 Jun; 2(3):379-89. PubMed ID: 16787118
[TBL] [Abstract][Full Text] [Related]
15. Tumor immunology.
Shu S; Plautz GE; Krauss JC; Chang AE
JAMA; 1997 Dec; 278(22):1972-81. PubMed ID: 9396660
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy approaches targeting regulatory T-cells.
Onishi H; Morisaki T; Katano M
Anticancer Res; 2012 Mar; 32(3):997-1003. PubMed ID: 22399623
[TBL] [Abstract][Full Text] [Related]
17. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
18. Suppression of anti-cancer immunity by regulatory T cells: back to the future.
Orentas RJ; Kohler ME; Johnson BD
Semin Cancer Biol; 2006 Apr; 16(2):137-49. PubMed ID: 16376101
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.
Roux S; Apetoh L; Chalmin F; Ladoire S; Mignot G; Puig PE; Lauvau G; Zitvogel L; Martin F; Chauffert B; Yagita H; Solary E; Ghiringhelli F
J Clin Invest; 2008 Nov; 118(11):3751-61. PubMed ID: 18830416
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells in cancer immunotherapy.
Nishikawa H; Sakaguchi S
Curr Opin Immunol; 2014 Apr; 27():1-7. PubMed ID: 24413387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
